Main Menu
Menu

Council for Innovation Promotion

Publish Date
Press Releases
Council for Innovation Promotion Applauds Senate Judiciary Committee Advancement of the NO FAKES Act

WASHINGTON (June 18, 2026) — Today, the Senate Judiciary Committee voted to advance the bipartisan Nurture Originals, Foster Art, and Keep Entertainment...

Op-Eds
Intellectual property supports the U.S. economy. It should be respected abroad.
The Washington Post
Press Releases
Council for Innovation Promotion Urges Senate Judiciary Committee To Advance NO FAKES Act

WASHINGTON (June 16, 2026) — On June 18, the Senate Judiciary Committee will vote on whether to advance the bipartisan Nurture Originals,...

Resources
Letters
C4IP Letter to Senate HELP Committee RE: Consideration of Medication Affordability and Patent Integrity Act
Blog
Inventor Spotlight: Robert Goddard

C4IP is recognizing Robert Goddard (1882-1945), the “Father of American Rocketry,” whose numerous patented inventions enabled modern spaceflight. Goddard was born amid...

News
C4IP Opposes Prohibiting Adversarial Patents Act, Releases Technology Ecosystems Report
IPWatchdog
News
Prohibiting Adversarial Patents Act Would Limit Patent Rights of National Security-Designated Entities
IPWatchdog
Videos
IP at America’s 250th
Press Releases
Council for Innovation Promotion Urges Congress to Reconsider the Prohibiting Adversarial Patents Act

WASHINGTON (June 10, 2026) — Representatives John Moolenaar (R-MI), Scott Fitzgerald (R-WI), and Darrell Issa (R-CA) recently introduced the Prohibiting Adversarial Patents...

C4IPResources
Letters
C4IP Letter to Senate HELP Committee RE: Medication Affordability and Patent Integrity Act Markup
News
Lawmakers warn against weakening IP for medicines in House hearing
Bio.News
Press Releases
Council for Innovation Promotion Releases Report from Prof. Jonathan Barnett on the Role of IP in Innovation, Competition, and Technology Leadership

WASHINGTON (June 8, 2026) — Today, the Council for Innovation Promotion (C4IP) released a new report independently authored by Professor Jonathan Barnett...

Op-Eds:

Op-Eds:

When inventors get an AI assist, who gets the patent?,

01/31/2024
Op-Eds:

Op-Eds:

The Biden administration should not support a WTO petition to strip IP protections from Covid-19 treatments,

01/31/2024
Resources:

Resources:

C4IP Comments RE: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement,

01/30/2024
Resources:

Resources:

C4IP Comments RE: Special 301 Review,

01/30/2024
News:

News:

Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better,

01/30/2024
News:

News:

The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows,

01/29/2024
Blog:

Blog, Fact Checks:

Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices,

01/29/2024
Op-Eds:

Op-Eds:

Biden’s Bayh-Dole Act proposal misuses ‘march-in rights’,

01/25/2024
Op-Eds:

Blog, Op-Eds:

Europe Stands at a Crossroads on Technology Policy,

01/24/2024
Videos:

Videos:

Briefing on the Bayh-Dole Act and March-In Rights,

01/24/2024
Resources:

Resources:

C4IP Letter to EU Parliament RE: Proposed EU SEP Regulation,

01/23/2024
News:

News:

Proposed ‘price’ criteria for march-in rights poses threat to U.S. innovation, critics say,

01/23/2024
Scroll to Top